Literature DB >> 8558156

Hemifacial spasm: a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom.

R D Illingworth1, D G Porter, J Jakubowski.   

Abstract

OBJECTIVE: To evaluate the use of microvascular decompression (MVD) for the treatment of hemifacial spasm (HFS).
METHODS: Eighty three patients with HFS who underwent MVD via a suboccipital craniectomy are presented.
RESULTS: Seventy two out of seventy eight patients available for follow up remained free of any spasms at a mean follow up period of eight years. Two patients continued to have minor intermittent muscle twitches and three had recurrence of HFS. One patient's operation was not completed. Twenty had a transient complication and eight were left with permanent postoperative deficits, the commonest being unilateral sensorineural deafness. Seventy one patients declared themselves satisfied with the procedure. A causative vessel was found on the root exit zone of the seventh cranial nerve in 81 patients.
CONCLUSION: The procedure seems to provide lasting relief for most patients. The correct operative technique is essential if complications are to be avoided.

Entities:  

Mesh:

Year:  1996        PMID: 8558156      PMCID: PMC486193          DOI: 10.1136/jnnp.60.1.72

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

Review 1.  Microvascular compression: an alternative view and hypothesis.

Authors:  C B Adams
Journal:  J Neurosurg       Date:  1989-01       Impact factor: 5.115

Review 2.  Hemifacial spasm: a review.

Authors:  R H Wilkins
Journal:  Surg Neurol       Date:  1991-10

3.  Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study.

Authors:  J D Taylor; S P Kraft; M S Kazdan; M Flanders; W Cadera; R B Orton
Journal:  Can J Ophthalmol       Date:  1991-04       Impact factor: 1.882

4.  Neurovascular decompression for cranial rhizopathies.

Authors:  K Panagopoulos; M Chakraborty; C E Deopujari; R P Sengupta
Journal:  Br J Neurosurg       Date:  1987       Impact factor: 1.596

5.  Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984.

Authors:  R G Auger; J P Whisnant
Journal:  Arch Neurol       Date:  1990-11

6.  Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.

Authors:  H K Kalra; E H Magoon
Journal:  Ophthalmic Surg       Date:  1990-05

7.  Interaction between the blink reflex and the abnormal muscle response in patients with hemifacial spasm: results of intraoperative recordings.

Authors:  A R Møller
Journal:  J Neurol Sci       Date:  1991-01       Impact factor: 3.181

8.  Intraoperative monitoring of the facial nerve during decompressive surgery for hemifacial spasm.

Authors:  S J Haines; F Torres
Journal:  J Neurosurg       Date:  1991-02       Impact factor: 5.115

9.  Monitoring facial EMG responses during microvascular decompression operations for hemifacial spasm.

Authors:  A R Møller; P J Jannetta
Journal:  J Neurosurg       Date:  1987-05       Impact factor: 5.115

Review 10.  The association of hemifacial spasm and facial pain.

Authors:  G D Perkin; R D Illingworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

View more
  19 in total

1.  Perforating branches from offending arteries in hemifacial spasm: anatomical correlation with vertebrobasilar configuration.

Authors:  T Nagatani; S Inao; Y Suzuki; J Yoshida
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Guidelines for the therapeutic use of botulinum toxin in movement disorders.

Authors:  C A Pagni
Journal:  Ital J Neurol Sci       Date:  1998-06

3.  Hemifacial spasm: a neurosurgical perspective.

Authors:  Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

4.  Chronologic analysis of symptomatic change following microvascular decompression for hemifacial spasm: value for predicting midterm outcome.

Authors:  Jae Sung Park; Doo-Sik Kong; Jeong-A Lee; Kwan Park
Journal:  Neurosurg Rev       Date:  2008-07-30       Impact factor: 3.042

5.  Prognostic factors of hemifacial spasm after microvascular decompression.

Authors:  Hong Rae Kim; Deok-Joo Rhee; Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

6.  Hemifacial spasm: treatment with pizotifen.

Authors:  M L Gross
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

7.  Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports.

Authors:  A M Childs; J F Meaney; C D Ferrie; P C Holland
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

8.  Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis.

Authors:  Katherine Holste; Ronald Sahyouni; Zoe Teton; Alvin Y Chan; Dario J Englot; John D Rolston
Journal:  World Neurosurg       Date:  2020-04-16       Impact factor: 2.104

9.  Clinical and electrophysiological studies of botulinum toxin type A to treat hemifacial spasm complicated with auricular symptoms.

Authors:  Bin Peng; Hongjuan Dong; Hong Chu; Shenqi Zhang; Zuneng Lu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 10.  Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review.

Authors:  Matthew Bartindale; Matthew Kircher; William Adams; Neelam Balasubramanian; Jeffrey Liles; Jason Bell; John Leonetti
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-12       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.